Related News

Home » Metro » Health and Science

New drug brings relief to orthopedic patients

AN innovative medicine is shown capable of preventing blood clots in the veins of patients who just received hip or knee replacement surgery. The new drug is now available in the Chinese market.

Made by Bristol-Myers Squibb and Pfizer, Eliquis can reduce the risk of venous thromboembolism (VTE) that occurs in some 60 percent of patients with major orthopedic surgeries seven to 14 days later.

VTE is also referred to as deep vein thrombosis if it clots leg veins or pulmonary embolism if it blocks lung arteries, doctors said.

Eliquis has been widely used in the Western countries and its import is a relief for patients in China where about 400,000 hip or knee replacement surgeries are performed each year, doctors said.


Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend